{"text":"Binding affinity towards human alpha-2 adrenergic receptor","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Compound was tested for plasma inhibition of Angiotensin I converting enzyme activity in the conscious rat. Expressed as Inhibition of AI pressor response at 6 hr at a dose of 12.1 mg\/kg po","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Compound was evaluated for the in vitro inhibition of the Butyrylcholinesterase from horse serum","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Compound was evaluated for DNA-binding affinity using poly[d(GC)]2","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Ability to interact with DNA was assessed by a DNA\/ethidium bromide dye displacement assay, expressed as DC50 for polydAdT","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"D2 receptor functional activity was measured through reversal of quinpirole inhibited, forskolin stimulated cAMP production from whole cells","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Histamine H2 receptor antagonistic activity at a concentration of 0.3 and 0.1 uM on the isolated guinea pig right atrium.","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Ratio of Kreact to that of Kinact was determined on human leukocyte elastase(HLE)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxic activity against human neuroblastoma IMR32 cells which over-express somatostatin receptors; na is not active","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of glycogen synthesis in rat skeletal muscle L6 cells (inactive)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibitory concentration against AD169 strain of HCMV in MRC5 cells","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Inhibitory activity against recombinant matrix metalloprotease-3","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Compound was evaluated for Inhibition of binding of [3H]- DAMGO at Rat brain mu receptor binding site, Expt-2","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity against HIV-Protease was determined","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]PGE-2 from human Prostaglandin E receptor EP3 expressed in CHO-KI cells","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Ability to displace ethidium bromide from double stranded synthetic Poly (dA-dT)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"The compound was tested for its binding affinity to Poly (dG-dC) by using ethidium displacement assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against Vibrio cholerae 0139","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"5-HTP accumulation in limbic system was determined in vivo","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Ratio of cytochrome P450 19A1 Ki for 6-alpha substituted steroid relative to 6-beta substitution","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding potency towards Delta opioid receptor of mouse vas deferens","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity towards human 5-hydroxytryptamine receptor 6 expressed in HeLa cells using the radioligand [3H]LSD","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Ratio of the MIC value of the Mycobacterium tuberculosis ) isoniazid resistant strain to H37Rv strain was determined","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Inhibition of [3H]CGS-21680 binding to adenosine A2a receptor of human striatal membrane","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity for human 5-hydroxytryptamine 3 serotonin membrane receptor using [3H]GR-65630","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of TNF-alpha-induced E-selectin expression in HUVEC cells at 90 ug\/ml after 2 hrs by flow cytometry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human ERalpha","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of HER2 at 1 uM","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as melting temperature at 2.2 uM","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of human NTS1 receptor at 1 uM","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to negatively supercoiled Escherichia coli pBR322 DNA assessed as DNA intercalation at 10 to 20 uM at pH 8 after 30 mins by DNA unwinding assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to negatively supercoiled Escherichia coli pBR322 DNA assessed as DNA intercalation at 20 to 50 uM at pH 6 after 30 mins by DNA unwinding assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to oligonucleotide HTG21 by florescence titration assay in presence of K+ solution","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to F10T hairpin duplex DNA assessed as change in melting temperature at 1 uM by FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Anxiolytic-like activity in ddY mouse assessed as ambulatory activity at 1 mg\/kg, po for 7 days measured 24 hrs after final drug administration assessed per 5 mins by tilting type ambulometer test","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as decrease in helical B conformation at 245 nanometer wavelength by circular dichroism","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human HOP62 cells assessed as age growth inhibition at 100 uM after 48 hrs by sulforhodamine B assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of luciferin binding site of Photuris pennsylvanica luciferase by competitive KinaseGlo Plus Max luminescent assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]estradiol from human recombinant estrogen receptor alpha by radiometric assay relative to estradiol","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to single stranded AT-rich oligonucleotide assessed as retardation of oligonucleotide movement by agarose gel electrophoresis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to G-quadruplex F21T DNA assessed as change in melting temperature at 3 uM under K+ ionic conditions by FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to Plasmodium falciparum spermidine synthase by saturation transfer difference-NMR experiment","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]MK912 from human cloned adrenergic alpha-2a receptor at 10 uM","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human KHS1","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA in sodium cacodylate buffer assessed as melting temperature at compound\/DNA ratio 0.1 at pH 7","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA in sodium cacodylate buffer assessed as melting temperature at compound\/DNA ratio 0.2 at pH 7","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against daptomycin-nonsusceptible Staphylococcus aureus isolate 703 bloodstream form isolated from patient with endocarditis assessed as bacterial survival rate at 20 ug\/ml after 2 hrs","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antibacterial activity against Clostridium difficile CD5 expressing tet(W) gene","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding affinity to Escherichia coli pUC19 DNA assessed as form 1 DNA level at 0.320 mM after 25.35 hrs by agarose gel electrophoresis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of Torpedo california AChE at 25 uM by Ellman's method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of 26S proteasome beta 2 in human HEK293 cell lysate assessed as residual activity at 0.03 uM after 1 hr","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of electric eel AChE at 10 uM by Ellman's assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antilipolytic activity in po dosed rat assessed as reduction plasma free fatty acids levels","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antagonist activity at mouse cloned Smo receptor expressed in NIH-3T3 cells co expressing Gli1 binding site after 15 hrs by luciferase reporter gene assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to (CAG-CAG) trinucleotide repeats at 120 uM by ESI-TOF mass spectroscopy","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Ratio of IC50 for inhibition of HIV1 HXB2 gp120-mediated viral infusion into HEK293 cells in presence of 45 mg\/ml human serum albumin to IC50 for inhibition of HIV1 HXB2 gp120-mediated viral infusion into HEK293 cells in absence of 45 mg\/ml human serum albumin","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiplasmodial activity against Plasmodium falciparum D10 ATCC 563 after 72 hrs by SYBR green assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antimicrobial activity against Staphylococcus epidermidis C960 by broth microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Inhibition of human MAPKAP-K3 at 10 uM after 60 mins by TR-FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiviral activity against Influenza A virus (A\/Vietnam\/1203\/2004 (H5N1)) infected in MDCK cells selected at 5 nM of zanamivir after 2 passage after 48 hrs by hemagglutininin titer assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antiviral activity against Hepatitis C virus subtype 1b expressing NS3 R155K mutant infected in HuH7 cells after 48 hrs by by luciferase reporter assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antimicrobial activity against 5-fluorocytosine resistant Candida glabrata isolate TE34-78 harboring Fcr1 L136R mutant assessed as lowest concentration inhibiting growth >=80% by broth microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antibacterial activity against Salmonella by broth macrodilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Displacement of [3H]SCH233930 from human D1 receptor expressed in HEK cells","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding constant for DRAK1 kinase domain","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to telomeric G-quadruplex DNA 5'-d(AGGGTTAGGGTTAGGGTTAGGG) assessed as increase in melting temperature at 2 uM by UV thermal denaturation analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to telomeric G-quadruplex DNA 5'-d(AOxodGGTTAGGGTTAGGGTTAGGGTGTT) at 1 to 10 uM by CD titration method in presence of 100 mM of KCl","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to telomeric G-quadruplex DNA 5'[32P]-d(AGGGTTAGGGTTAOxodGGGGTTAGGGTGTT) at 1 to 10 uM by CD titration method in presence of 100 mM of KCl","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human telomeric AGGG(TTAGGG)3 quadruplex assessed as fluorescence quenching at 10 uM after 3 mins by fluorescence titration method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to Schizosaccharomyces pombe Thiolated Lys-tRNA using 32P-labelled probe by PAGE analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to Schizosaccharomyces pombe Non-thiolated Met-tRNA using 32P-labelled probe by PAGE analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to DNA assessed as increase in hypochromicity by UV-spectroscopic analysis with compound pretreatment with CYP450","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against erythromycin-sensitive Staphylococcus aureus ATCC 13709 by broth microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding affinity to calf thymus DNA assessed as change in melting temperature at 1 uM by spectrophotometry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of A73U tRNA(Tyr)-5'Rhd-AM1A T box antiterminator RNA complex assessed as reduction in anisotrophy changes by at 100 uM by fluorescence anisotropy-based assay relative to untreated control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against Bacillus at 10 mg\/ml after 24 hrs by cut-plug method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding affinity to calf thymus DNA assessed as bathochromic shift at 1 x 10'-5 M by UV-Vis spectroscopy","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as hypochromicity at 1 x 10'-5 M by UV-Vis spectroscopy","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to 5'-ACACGT-3' sequence in 125 bp 5'-[32P]-radiolabeled DNA at 100 uM after 30 mins by DNase1 footprinting analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to 5'-AGCGCT-3' sequence in 125 bp 5'-[32P]-radiolabeled DNA at 100 uM after 30 mins by DNase1 footprinting analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to chicken blood dsDNA assessed as shift in Ep\/mv at 1 x 10 '-3 M at pH 4.7 by cyclic voltammetry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to chicken blood dsDNA assessed as decrease in current at 1 x 10 '-3 M at pH 7.4 by cyclic voltammetry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Antifungal activity against Penicillium funiculosum ATCC 36839 treated for 72 hrs followed by sub-cultivated for 5 days by serial dilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding affinity to poly-d(AT)2 DNA by UV titration analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to polyd(GC)2 DNA by UV titration analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as fluorescence quenching by fluorescence spectroscopy analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq\/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay relative to 1-(4-(6-benzylbenzofuran-2-yl)-3-fluorobenzyl)azetidine-3-carboxylic acid","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Growth inhibition of human CCRF-CEM cells assessed as cell growth at 10'-5 M after 48 hrs by SRB assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Anticonvulsant activity in mouse assessed as protection against subcutaneous pentylenetetrazole-induced seizures at 300 mg\/kg, ip after 4 hrs","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Fungicidal activity against Trichoderma viride CECT 2423 at 0.2 mg\/disk after 48 hrs by agar diffusion assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Displacement of [3H]epibatidine from rat alpha2beta4 nACHR at 10 uM","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of radioligand binding to human adrenergic alpha2c receptor at 10 uM","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Ratio of TXA IC50 to compound IC50 for human Glu-plasminogen\/fibrinogen interaction by clot-lysis buffer assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cell cycle arrest in human Bel7402 cells assessed as accumulation at S phase at 0.15 uM after 48 hrs by propidium iodide staining-based FACS analysis (Rvb = 39.17 %)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human adenosine A1 receptor by radioligand displacement assay","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells up to 0.1 mM after 2 hrs by scintillation counting analysis","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of human purified His-tagged DPP-7 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as intercalation after 2 hrs by Stern-Volmer plot relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Trypanocidal activity against bloodstream forms of Trypanosoma brucei brucei Lister 427 clone 221a after 72 hrs by AlamarBlue assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Inhibition of human recombinant SGK1 using ATP\/Ulight-RRRSLLE as substrate at 1 uM after 30 mins by LANCE assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Growth inhibition of Saccharomyces cerevisiae BY4742 harboring gcn5delta mutant after 48 hrs","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antagonist activity at Pseudomonas aeruginosa PAO1 LasR expressing lasI coexpressing LVA-GFP at 100 to 200 uM after 24 hrs by fluorescence assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to M4 receptor (unknown origin) by PDSP assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of Bcr\/Abl kinase tyrosine phosphorylation in human K562 cells after 1 hr by immunoblot analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Neuroprotective activity in glutamate-induced mouse HT22 cells assessed as decrease in ROS level at 1 uM after 12 hrs by H2DCF diacetate-based flow cytometric analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antitumor activity against mouse S180 cells allografted in ddY mouse assessed as tumor growth inhibition at 10 mg\/kg, po administered once every 2 days for 2 weeks relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of human p70S6K assessed as enzyme activity at 1 uM relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human A549 cells assessed as necrotic cells at 5 uM after 48 hrs by annexin V\/PI staining-based FACS analysis (Rvb = 2.8 %)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]AF-DX384 from human recombinant M2 receptor expressed in CHO cells","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to Escherichia coli ribosomes after 2 hrs by fluorescence polarization assay in presence of BODIPY-labeled erythromycin A","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antagonist activity at 5-HT2A receptor (unknown origin) at 10 mM by functional assay relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human HepG2 cells assessed as viable cells at 20 uM after 6 hrs by annexin V\/propidium iodide staining-based flow cytometric analysis (Rvb = 90.9%)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to RPA70N protein (unknown origin) by HSQC NMR-based titration method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 18 to 24 hrs by spectrophotometric analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Displacement of [3H]CP55940 from CB1 receptor in Wistar rat brain incubated for 60 mins by radioactive filter binding assay","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to NTSR1 in human HT-29 cells after 2 hrs by liquid scintillation counting","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of human liver cathepsin B using Cbz-Arg-Arg-pNA as substrate at pH 6 incubated for 30 mins measured for 20 mins by photometrical analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of human SRPK3 (41 to 567 amino acid residues) expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Potentiation of 2.5 nM (-)-lomaiviticin A-induced cytotoxicity against human K562 cells assessed as combination index at 10 uM after 48 hrs by cell titer-glo luminescence assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to His6-tagged human recombinant SMARCA2B bromodomain expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells by VP-ITC microcalorimetry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of PDK1 (unknown origin) by FRET-based Z-lyte assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to rat M2 receptor by radio-ligand binding assay","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Potency index, ratio of cyclosporine A IC50 to compound IC50 for ABCB1 in human A2780\/ADR cells","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Stabilization of BRAF in human K562 cells after 1 hr by thermal shift assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]NVP-QAW039 from human DP2 receptor expressed in CHO cell membranes assessed as association rate constant by TopCount scintillation assay","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against Escherichia coli MTCC 443 after 24 hrs by broth microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as time at which amplitude of ThT emission is 50% of difference between final and initial fluorescence emission at 40 to 5000 uM in presence of trehalose by ThT-based fluorometric method (Rvb = 11 +\/- 1 hrs)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of biotinylated histone H3K14 peptide ligand from human recombinant His-tagged BRD4 bromodomain-1 measured after 10 mins by TR-FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of SLK (unknown origin) at 0.19 uM relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]BRL 43694 from human recombinant 5-HT3 receptor at 10 uM after 120 mins by scintillation counting analysis relative to control","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human GABAA receptor alpha1beta3gamma2 expressed in HEK293 TetR cells assessed as photolabeling at 0.7 uM after 30 mins in presence of 300 uM GABA by coomassie blue staining based fluorographic method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of recombinant human N-terminal\/C-terminal His6-tagged PAK2 (3 to end residues) expressed in Escherichia coli at 10 uM by filter binding radioactive ATP transferase assay relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length BMPR1A (Q214 to I532 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of human recombinant C-terminal His tagged-AMPK alpha1\/beta1\/gamma2 kinase activity expressed in baculovirus infected insect Sf9 cells using SAMStide as substrate after 60 mins by ADP-glo assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antifungal activity against Candida albicans ATCC 90028 infected in Galleria mellonella larvae infected with 20 uM compound pre-treated cell suspensions assessed as melanization incubated in dark for 144 hrs at 30 degC and measured every 24 hrs (Rvb = 65%)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length ULK2 (M1 to S301 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of recombinant human His-tagged P38beta MAPK (1 to 364 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of class 1 HDAC in human Cal27CisR cells assessed as potentiation of cisplatin-induced apoptosis by measuring increase in accumulation at sub-G1 phase at 5 uM preincubated for 48 hrs followed by cisplatin addition and measured after 24 hrs by propidium iodide staining based flow cytometry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of (+)-[3H]pentazocine from sigma1 receptor in guinea pig brain membranes","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of 6N-FAM from SF1 LBD (218 to 461 residues) (unknown origin) expressed in Escherichia coli BL21 pLysS by competitive binding based fluorescence polarization assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of BCL6 degradation in human SUDHL-4 cells incubated for 2 hrs by immunofluorescence analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Potency index, ratio of [Nle15]MG11 IC50 to test compound IC50 for displacement of [177Lu] PP-F11N from CCK2R (unknown origin) transfected in A431 cells incubated for 1 hr at 4 degree C followed by compound washout with PBS buffer using Lu3+ labeled compound by Cobra-2 gamma counter method","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of wild-type human partial length PIM1 (A15 to K313 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human partial length TRIM33 (D882 to A1087 residues) expressed in bacterial expression system at 1 uM by BROMOscan assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]4-DAMP from recombinant human M3 receptor after 60 mins by scintillation counting analysis","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human partial length PIK3CA E545A mutant (R108 to N1068 residues) expressed in mammalian expression system measured after 1 hr by kinomescan method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length autoinhibited FLT3 (H564 to Y969 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length SBK1 (P23 to P348 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to zanamivir\/oseltamivir resistant recombinant Influenza A virus (A\/Moscow\/10\/99(H3N2)) Neuraminidase N2 E119V\/I222L double mutant expressed in baculovirus infected insect cells at 100 to 1000 nM measured up to 160 sec by surface plasmon resonance analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to SOX2 promoter 5'-CTTTGTT-3' DNA in mouse Hepa1 cells assessed as reduction in SOX2 mRNA expression incubated for 48 hrs by qRT-PCR analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Antiinflammatory activity in mouse T cells assessed as inhibition of conA-induced induced T cell proliferation at 2 uM incubated for 48 hrs by CCK8 assay relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA after 24 hrs by UV-vis spectroscopy","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as change in melting temperature at DNA to ligand ratio at 40:1 by spectrophotometric method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Antiallodynic activity in oxaliplatin-induced peripheral neuropathy pain CD-1 mouse model assessed as inhibition of late-phase tactile allodynia by measuring pain sensitivity threshold at 22.5 mg\/kg administered with compound intraperitoneally at 7 days after oxaliplatin stimulation and measured after 30 mins by von Frey test (Rvb = 65.3%)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of 5-(3-((1r,4r)-4-((5S,8S,11S,14S,17S,20S,29S)-11-((1H-imidazol-4-yl)methyl)-1,33-diamino-5-carbamoyl-17-(4-(4-(4-((4-(dimethylamino)phenyl)diazenyl)phenyl)butanamido)butyl)-8,14-bis(3-guanidinopropyl)-20-methyl-7,10,13,16,19,22,25,28-octaoxo-6,9,12,15,18,21,24,27-octaazatritriacontan-29-ylcarbamoyl)cyclohexyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid binding to SIRT2 (unknown origin) measured after 2 hrs in presence of NAD+ by fluorometric method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human HCC827 cells assessed as early apoptotic cells at 1 uM measured after 24 hrs by Annexin V-FITC\/propidium iodide staining based flow cytometry (Rvb = 2.49%)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to HPGDS (unknown origin) assessed as change in melting temperature by thermal shift assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of RSK1 in human TE-10 cells assessed as suppression of P27KIP1 phosphorylation at 1 to 10 uM measured after 24 hrs by Western blot analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]-SCH23390 from D3 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human Ramos cells assessed as cell death incubated at 10 uM for 20 hrs measured by DNS assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Partial agonist activity at GAL4-tagged human PPARgamma LBD expressed in HEK293T cells at 10 uM incubated for 12 to 14 hrs by dual-Glo luciferase assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antitumor activity against human Raji cells xenografted in NOD-SCID mouse assessed as tumor growth inhibition at 1.5 mg\/kg, po administered for 25 days","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiproliferative activity against human SNU-16 cells assessed as inhibition of cell proliferation incubated for 5 days by CCK-8 assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Potency index, ratio of Miglitol Ki to test compound Ki for inhibition of jack bean alpha-mannosidase measured per DNJ unit","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of CDK9\/Cyclin T1 degradation in human 22Rv1 cells assessed as downregulation of AR-V7 splice variant protein expression at 2 uM measured after 24 hrs by immunoblot analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Protac activity at CRBN\/CDK13 in human MDA-MB-231 cells assessed as degradation of CDK13 at 500 nM measured after 6 hrs in presence of carfilzomib by Western blot analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human Sirt3 (118 to 399 residues) assessed as dissociation constant (Koff) of ternary complex using acetylated MnSOD peptide as substrate in presence of OAADPr by short DNA nano levers based switchSENSE microfluid bio-chip analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human G-quadruplex telomeric DNA F21T (5'-duplex FAM-GGGTTAGGGTTAGGGTTAGGG-TAM-3') assessed as stabilization by measuring change in melting temperature at 5 uM by FRET melting assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of human ERG at 10 uM relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
